US20110054420A1 - Reduced-pressure wound dressings and systems for re-epithelialization and granulation - Google Patents
Reduced-pressure wound dressings and systems for re-epithelialization and granulation Download PDFInfo
- Publication number
- US20110054420A1 US20110054420A1 US12/857,179 US85717910A US2011054420A1 US 20110054420 A1 US20110054420 A1 US 20110054420A1 US 85717910 A US85717910 A US 85717910A US 2011054420 A1 US2011054420 A1 US 2011054420A1
- Authority
- US
- United States
- Prior art keywords
- water
- sensitive
- reduced
- epithelialization
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000005469 granulation Methods 0.000 title claims abstract description 54
- 230000003179 granulation Effects 0.000 title claims abstract description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 73
- 230000004888 barrier function Effects 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 25
- 230000001737 promoting effect Effects 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims description 76
- 230000009969 flowable effect Effects 0.000 claims description 55
- 210000001519 tissue Anatomy 0.000 claims description 42
- 238000007789 sealing Methods 0.000 claims description 21
- 210000002615 epidermis Anatomy 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 15
- 239000006260 foam Substances 0.000 claims description 14
- 239000000017 hydrogel Substances 0.000 claims description 13
- 230000001939 inductive effect Effects 0.000 claims description 11
- 206010052428 Wound Diseases 0.000 abstract description 44
- 208000027418 Wounds and injury Diseases 0.000 abstract description 44
- 230000029663 wound healing Effects 0.000 abstract description 4
- 239000000416 hydrocolloid Substances 0.000 description 7
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- -1 open-cell Polymers 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002943 EPDM rubber Polymers 0.000 description 1
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229920002681 hypalon Polymers 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/912—Connectors between dressing and drainage tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/95—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with sensors for exudate composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
Definitions
- the present disclosure relates generally to medical treatment systems and, in particular but not by way of limitation, to reduced-pressure wound dressings, systems, and methods for re-epithelialization and granulation of a wound.
- the physiological process of wound healing involves different phases that may occur simultaneously or sequentially. As used herein, “or” does not require mutual exclusivity. Two phases of the wound healing process involve granulation (proliferation) and re-epthiliazation.
- a method for promoting granulation and re-epithelialization of a wound includes the steps of providing a reduced-pressure treatment dressing having a first side and a second, tissue-facing side.
- the second, tissue-facing side of the reduced-pressure treatment dressing has a micro-strain inducing surface.
- the method further includes the steps of creating a moist, water-sensitive barrier on portions of the wound to promote re-epithelialization and to inhibit granulation; placing the reduced-pressure treatment dressing adjacent to the wound; and causing a fluid seal over the reduced-pressure treatment dressing.
- the method also includes applying reduced pressure to the reduced-pressure treatment dressing.
- a system for promoting granulation and re-epithelialization of a wound of a patient includes a reduced-pressure treatment dressing and a moist, water-sensitive barrier disposed adjacent the reduced-pressure treatment dressing at portions of the wound to promote re-epithelialization and to inhibit granulation.
- the system further includes a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient and a reduced-pressure source for providing reduced pressure to the reduced-pressure treatment dressing.
- a kit for deploying a dressing for promoting granulation and re-epithelialization of a wound of a patient includes a reduced-pressure treatment dressing and a water-sensitive, flowable material for disposing adjacent to the reduced-pressure treatment dressing at portions of the wound to promote re-epithelialization and to inhibit granulation.
- the kit also includes a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient.
- the kit may also include a reduced-pressure delivery conduit for providing reduced pressure to the reduced-pressure treatment dressing.
- the kit includes a delivery device for applying the water-sensitive, flowable material.
- FIG. 1 is a schematic diagram with a portion in cross section of an illustrative, non-limiting embodiment of a system and dressing for re-epithelialization and granulation of a wound;
- FIG. 2 is a schematic, cross-sectional view of a wound to which a moist, water-sensitive barrier is being applied to a portion of the tissue;
- FIG. 3 is a schematic, perspective view of water-sensitive, flowable material being applied to a reduced-pressure treatment dressing
- FIG. 4 is a schematic, perspective view of an illustrative, non-limiting embodiment of a wound dressing.
- FIG. 1 an illustrative, non-limiting embodiment of a wound treatment system 100 that facilitates granulation and re-epithelialization is presented.
- the system 100 is shown deployed for treatment of a tissue site 102 and, in particular, a wound 104 .
- the wound 104 is shown extending through epidermis 112 and into subcutaneous tissue 114 .
- a peri-wound area may include the wound 104 and intact tissue near the wound 104 or may include the wound 104 alone.
- the tissue site 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue.
- the wound treatment system 100 facilitates re-epithelialization of a portion of the tissue site 102 and facilitates granulation of another portion of the tissue site 102 with both potentially occurring at the same time.
- the wound 104 may have wound edges 106 and may include one or more islands of intact epidermis, such as island 108 of intact epidermis, which has wound edges 110 .
- the wound 104 may be regarded as including wound edges 106 , 110 .
- the epithelialization, or re-epithelialization, phase of acute wound healing involves resurfacing of the wound 104 and changes in the wound edges 106 , 110 .
- the process protects a patient's body from invasion by outside organisms and may occur concurrently with other phases if not restricted.
- the resurfacing aspect involves keratinocytes.
- Keratinocytes form layers of the dermis and epidermis. Keratinocytes are derived from epidermal stem cells located in the bulge area of hair follicles and migrate from that location into the basal layers of epidermis. The keratinocytes proliferate and differentiate to produce epidermis and thereby replenish the epidermis. Keratinocytes may respond to signals released from growth factors, which may be in wound exudate, by advancing in a sheet to resurface a space. Because of this migration, a moist wound environment may speed the migration of keratinocytes toward one another from the wound edges 106 , 110 . The wound treatment system 100 promotes the re-epithelialization phase or process and the granulation phase or process.
- the wound treatment system 100 includes a moist barrier 116 , a reduced-pressure treatment dressing 118 , and a sealing member 120 .
- the reduced-pressure treatment dressing 118 When the wound treatment system 100 is deployed, the reduced-pressure treatment dressing 118 will be disposed adjacent to portions of the tissue site 102 where primarily granulation is desired and adjacent the moist barrier 116 in other locations.
- the moist barrier 116 will be adjacent to portions of the tissue site 102 where primarily re-epithelialization is to be promoted and where granulation is to be inhibited or not facilitated.
- the moist barrier 116 reduces or prevents reduced pressure from being experienced at the location covered by the moist barrier 116 or reduces or prevents contact by a micro-strain-inducing surface of a manifold 128 of the reduced-pressure treatment dressing 118 .
- the sealing member 120 is deployed.
- the sealing member 120 is deployed over the reduced-pressure treatment dressing 118 and a portion of a patient's intact epidermis 112 .
- the sealing member 120 has a first side 121 and a second, tissue-facing side 123 .
- the sealing member 120 may be formed from any material that provides a fluid seal. “Fluid seal,” or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved.
- the sealing member may, for example, be an impermeable or semi-permeable, elastomeric material.
- “Elastomeric” means having the properties of an elastomer. Elastomer generally refers to a polymeric material that has rubber-like properties. More specifically, most elastomers typically have ultimate elongations greater than 100% and a significant amount of resilience.
- the resilience of a material refers to the material's ability to recover from an elastic deformation.
- elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane, EVA film, co-polyester, and silicones.
- Additional examples of sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif.
- An attachment device 122 may be used to form a fluid seal between the epidermis 112 and the sealing member 120 .
- the attachment device 122 may be used to hold the sealing member 120 against the patient's epidermis 112 or another layer, such as a gasket or additional sealing member.
- the attachment device 122 may take numerous forms.
- the attachment device 122 may be a medically acceptable, pressure-sensitive adhesive 124 that extends about a periphery of the sealing member 120 .
- the reduced-pressure treatment dressing 118 which has a first side 130 and a second, tissue-facing side 132 , may be any dressing that distributes reduced pressure and that may help promote micro-strain at the tissue site 102 .
- the reduced-pressure treatment dressing 118 may be or include the manifold 128 .
- the term “manifold” as used herein generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from the tissue site 102 .
- the manifold 128 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the tissue site 102 around the manifold 128 .
- the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from the tissue site 102 .
- the manifold 128 may be a biocompatible material that is capable of being placed in contact with the tissue site 102 and distributing reduced pressure to the tissue site 102 .
- manifold 128 may include, for example, without limitation, devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels.
- the manifold 128 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application.
- the manifold 128 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels.
- the porous foam may be a polyurethane, open-cell, reticulated foam, such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex.
- the manifold 128 has a first side 129 and a second, tissue-facing side 131 .
- the second, tissue-facing side 131 may provide a micro-strain-inducing surface, such as open cells or protrusions or other devices that impinge on the tissue site 102 when under reduced pressure or a force.
- the manifold 128 may be constructed from bioresorbable materials that do not have to be removed from a patient's body following use of the reduced-pressure treatment dressing 118 .
- Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA).
- the polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones.
- the manifold 128 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the manifold 128 to promote cell-growth.
- a scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth.
- Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- the manifold 128 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions to the tissue site 102 .
- Other layers may be included in or on the manifold 128 , such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials.
- a reduced-pressure connector 134 may be associated with the reduced-pressure treatment dressing 118 to provide reduced pressure thereto.
- the reduced-pressure connector 134 may have a flange portion 136 that may be disposed between the sealing member 120 and the first side 130 of the reduced-pressure treatment dressing 118 .
- a portion of the reduced-pressure connector 134 extends through a connector aperture 138 in the sealing member 120 .
- a reduced pressure delivery conduit 140 may be used to fluidly couple the reduced-pressure connector 134 to a reduced-pressure source 142 .
- One or more devices 144 may be associated or fluidly coupled to the reduced-pressure delivery conduit 140 .
- the device or devices 144 that may be fluidly coupled to the reduced-pressure delivery conduit 140 include, for example, without limitation, a fluid reservoir or collection member to hold exudates and other fluids removed, a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a flow monitoring system, a temperature monitoring system, or other device.
- the reduced-pressure source 142 provides reduced pressure as a part of the system 100 .
- reduced pressure generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure of tissue at the tissue site.
- vacuum and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be significantly more than the pressure normally associated with a complete vacuum. Unless otherwise indicated, values of pressure stated herein are gauge pressures.
- the reduced pressure delivered by the reduced-pressure source 142 may be constant or varied (patterned or random) and may be delivered continuously or intermittently.
- the reduced-pressure source 142 may be a battery-powered, reduced-pressure generator. This facilitates application in the operating room and provides mobility and convenience for the patient during the rehabilitation phase.
- Other sources of reduced pressure might be utilized, such as V.A.C.® therapy unit, which is available from KCI of San Antonio, Tex., wall suction, a mechanical unit, or a micro-pump imbedded in the reduced-pressure treatment dressing 118 .
- the pressure may in the range of ⁇ 5 mm Hg to ⁇ 500 mm Hg and more typically between ⁇ 100 mm Hg and ⁇ 200 mm Hg.
- the reduced pressure developed by the reduced-pressure source 142 is delivered through the reduced-pressure delivery conduit 140 , or medical conduit or tubing, to the reduced-pressure connector 134 .
- a hydrophobic membrane filter may be interspersed between the reduced-pressure delivery conduit 140 and the reduced-pressure source 142 .
- reduced pressure is delivered by a micro-pump to a sealed spaced under the sealing member 120 .
- the moist barrier 116 may be formed from numerous materials.
- the moist barrier 116 is a moist, water-sensitive barrier, such as a hydrogel, hydrocolloid, or other part solid solution.
- the moist barrier 116 may also be a substance in a foam formulation such as a hydrogel or hydrocolloid foam form or may be an emulsified oil.
- the material from which the moist barrier 116 is formed may be water-sensitive, or a fluid balancing material, meaning that the material will provide moisture to dry wounds and will absorb moisture from excessively moist, or wet, wounds.
- the moist barrier 116 may be a water-sensitive, flowable material 146 , such as a flowable hydrogel or flowable hydrocolloid.
- the moist barrier 116 may include additional substances, such as growth factors.
- the moist barrier 116 may promote bio-mimicry.
- the water-sensitive, flowable material 146 may be a high viscosity fluid, like a flowable hydrogel or hydrocolloid that is low enough in viscosity to flow, but high enough in viscosity to occlude the reduced-pressure treatment dressing 118 .
- the water-sensitive, flowable material 146 may move partially into the manifold 128 .
- the degree to which the water-sensitive, flowable material 146 moves into the manifold 128 is, in the case of a foam manifold, governed primarily by pore size, the level of reduced pressure, and the viscosity of the water-sensitive, flowable material 146 .
- the water-sensitive, flowable material 146 may have a viscosity in the range of 2,000 to 250,000 centipoise (cP) at 25° C. As another illustrative, non-limiting example, the water-sensitive, flowable material 146 may have a viscosity in the range of 50,000 to 150,000 cP at 25° C.
- the water-sensitive, flowable material 146 may be a gel that is pseudoplastic (capable of shear thinning, i.e., shear dependent viscosity) so that the material has a low viscosity as dispensed with high shear, but once in place with a low shear situation, the material increases in viscosity.
- pseudoplastic capable of shear thinning, i.e., shear dependent viscosity
- the moist barrier 116 is typically deployed in a position to cover the wound edges 106 , 110 and may be deployed in a number of ways. Referring now primarily to FIG. 2 , one illustrative, non-limiting description of a process for forming the moist barrier 116 is presented.
- the moist barrier 116 comprises the water-sensitive, flowable material 146 .
- a delivery device 150 such as a squirtable container of material, a syringe 152 , or other device, is used to deliver the water-sensitive, flowable material 146 directly to portions of the tissue site 102 where granulation is not desired, but re-epithelialization is desired. In this way, the moist barrier 116 is formed in situ.
- the water-sensitive, flowable material 146 may provide a moist environment for the portions of the tissue site 102 that are covered by the water-sensitive, flowable material 146 , and the water-sensitive, flowable material 146 restricts or prevents reduced pressure from being delivered through the reduced-pressure treatment dressing 118 to the covered tissue or otherwise prevents micro-strain from being induced at the covered locations.
- the reduced-pressure treatment dressing 118 is formed from an open cell foam
- the water-sensitive, flowable material 146 may occlude cells that contact the water-sensitive, flowable material 146 .
- the delivery device 150 e.g., the syringe 152
- the delivery device 150 is used to apply a water-sensitive, flowable material 146 onto the second, tissue-facing side 131 of the manifold 128 .
- the water-sensitive, flowable material 146 is applied at locations on the second, tissue-facing side 131 of the manifold 128 that correspond or align, when deployed, with the portions of the tissue site 102 where granulation is not desired and re-epithelialization is desired.
- a layer 154 of water-sensitive material is applied to the second, tissue-facing side 131 of the manifold 128 and substantially covers the second, tissue-facing side 131 of the manifold 128 .
- the layer 154 includes perforations or cuts 156 that readily allow one to remove one or more segments, or portions 158 , of the layer 154 to expose a portion of the second, tissue-facing side 131 of the manifold 128 .
- the segments 158 may be removed that correspond, when deployed, to portions of the tissue site 102 where granulation is desired.
- the reduced-pressure treatment dressing 118 When the reduced-pressure treatment dressing 118 is deployed with the second, tissue-facing side 131 adjacent the tissue site 102 , the remaining portions of the layer 154 that form the moist barrier 116 will be adjacent to the areas where no granulation is desired but re-epthiliazation is desired. At the same time, the second, tissue-facing side 131 of the manifold 128 will be against the portions of the tissue site 102 where granulation is desired.
- the moist barrier 116 may be formed from a hydrogel, hydrocolloid, or other material.
- the hydrogel or hydrocolloid may be cast onto a woven liner and cross-linked.
- the hydrogrel or hydrocolloid is not mobile.
- the moist barrier 116 is placed adjacent to the portion of the tissue site 102 where granulation is not desired and where re-epithelialization is desired.
- the second, tissue-facing side 131 of the manifold 128 is placed directly adjacent to the portion of the tissue site 102 where granulation is desired.
- the sealing member 120 is placed over the tissue site 102 and a portion of the patient's intact epidermis 112 to form a fluid seal. Reduced pressure is supplied to the manifold 128 .
- a kit for deploying a dressing for promoting granulation and re-epithelialization of a wound of a patient may be formed that provides an easy and convenient manner to treat a wound.
- the kit may include a reduced-pressure treatment dressing (e.g., reduced-pressure treatment dressing 118 ) and a water-sensitive, flowable material (e.g., water-sensitive, flowable material 146 ) for disposing adjacent to the reduced-pressure treatment dressing (e.g., reduced-pressure dressing 118 ) at locations on the wound where granulation is not desired and where re-epithelialization is desired.
- the kit also may include a sealing member (e.g., sealing member 120 ) for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient and may include a reduced-pressure delivery conduit (e.g., reduced-pressure delivery conduit 140 ) for providing reduced pressure to the reduced-pressure treatment dressings.
- the kit may include a delivery device (e.g., delivery device 150 ) for applying the water-sensitive, flowable material and may include a reduced-pressure connector (e.g., reduced-pressure connector 134 ).
Abstract
Methods, apparatuses, and systems for promoting re-epithelialization and granulation as an aspect of wound healing are presented. A method and system for promoting granulation and re-epithelialization of a wound at the same time involves using a reduced-pressure treatment dressing and applying a moist, water-sensitive barrier to promote re-epithelialization and to inhibit granulation. Other systems, apparatuses, and methods are presented.
Description
- The present invention claims the benefit, under 35 USC §119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/237,504 entitled “Reduced-Pressure Wound Dressings and Systems For Re-Epithelialization and Granulation,” filed Aug. 27, 2009, which is incorporated herein by reference for all purposes.
- The present disclosure relates generally to medical treatment systems and, in particular but not by way of limitation, to reduced-pressure wound dressings, systems, and methods for re-epithelialization and granulation of a wound.
- The physiological process of wound healing involves different phases that may occur simultaneously or sequentially. As used herein, “or” does not require mutual exclusivity. Two phases of the wound healing process involve granulation (proliferation) and re-epthiliazation.
- Improvements to certain aspects of wound care dressings, methods, and systems are addressed by the present invention as shown and described in a variety of illustrative, non-limiting embodiments herein. According to an illustrative, non-limiting embodiment, a method for promoting granulation and re-epithelialization of a wound includes the steps of providing a reduced-pressure treatment dressing having a first side and a second, tissue-facing side. The second, tissue-facing side of the reduced-pressure treatment dressing has a micro-strain inducing surface. The method further includes the steps of creating a moist, water-sensitive barrier on portions of the wound to promote re-epithelialization and to inhibit granulation; placing the reduced-pressure treatment dressing adjacent to the wound; and causing a fluid seal over the reduced-pressure treatment dressing. The method also includes applying reduced pressure to the reduced-pressure treatment dressing.
- According to an illustrative, non-limiting embodiment, a system for promoting granulation and re-epithelialization of a wound of a patient includes a reduced-pressure treatment dressing and a moist, water-sensitive barrier disposed adjacent the reduced-pressure treatment dressing at portions of the wound to promote re-epithelialization and to inhibit granulation. The system further includes a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient and a reduced-pressure source for providing reduced pressure to the reduced-pressure treatment dressing.
- According to an illustrative, non-limiting embodiment, a kit for deploying a dressing for promoting granulation and re-epithelialization of a wound of a patient includes a reduced-pressure treatment dressing and a water-sensitive, flowable material for disposing adjacent to the reduced-pressure treatment dressing at portions of the wound to promote re-epithelialization and to inhibit granulation. The kit also includes a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient. The kit may also include a reduced-pressure delivery conduit for providing reduced pressure to the reduced-pressure treatment dressing. Finally, the kit includes a delivery device for applying the water-sensitive, flowable material.
- Other features and advantages of the illustrative, non-limiting embodiments will become apparent with reference to the drawings and detailed description that follow.
-
FIG. 1 is a schematic diagram with a portion in cross section of an illustrative, non-limiting embodiment of a system and dressing for re-epithelialization and granulation of a wound; -
FIG. 2 is a schematic, cross-sectional view of a wound to which a moist, water-sensitive barrier is being applied to a portion of the tissue; -
FIG. 3 is a schematic, perspective view of water-sensitive, flowable material being applied to a reduced-pressure treatment dressing; and -
FIG. 4 is a schematic, perspective view of an illustrative, non-limiting embodiment of a wound dressing. - In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
- Referring now primarily to
FIG. 1 , an illustrative, non-limiting embodiment of awound treatment system 100 that facilitates granulation and re-epithelialization is presented. Thesystem 100 is shown deployed for treatment of atissue site 102 and, in particular, awound 104. Thewound 104 is shown extending throughepidermis 112 and intosubcutaneous tissue 114. A peri-wound area may include thewound 104 and intact tissue near thewound 104 or may include thewound 104 alone. Thetissue site 102 may be the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue. Thewound treatment system 100 facilitates re-epithelialization of a portion of thetissue site 102 and facilitates granulation of another portion of thetissue site 102 with both potentially occurring at the same time. Thewound 104 may havewound edges 106 and may include one or more islands of intact epidermis, such asisland 108 of intact epidermis, which haswound edges 110. Thewound 104 may be regarded as includingwound edges - The epithelialization, or re-epithelialization, phase of acute wound healing involves resurfacing of the
wound 104 and changes in thewound edges - Among other things, keratinocytes form layers of the dermis and epidermis. Keratinocytes are derived from epidermal stem cells located in the bulge area of hair follicles and migrate from that location into the basal layers of epidermis. The keratinocytes proliferate and differentiate to produce epidermis and thereby replenish the epidermis. Keratinocytes may respond to signals released from growth factors, which may be in wound exudate, by advancing in a sheet to resurface a space. Because of this migration, a moist wound environment may speed the migration of keratinocytes toward one another from the
wound edges wound treatment system 100 promotes the re-epithelialization phase or process and the granulation phase or process. - The
wound treatment system 100 includes amoist barrier 116, a reduced-pressure treatment dressing 118, and a sealingmember 120. When thewound treatment system 100 is deployed, the reduced-pressure treatment dressing 118 will be disposed adjacent to portions of thetissue site 102 where primarily granulation is desired and adjacent themoist barrier 116 in other locations. Themoist barrier 116 will be adjacent to portions of thetissue site 102 where primarily re-epithelialization is to be promoted and where granulation is to be inhibited or not facilitated. Among other things, themoist barrier 116 reduces or prevents reduced pressure from being experienced at the location covered by themoist barrier 116 or reduces or prevents contact by a micro-strain-inducing surface of amanifold 128 of the reduced-pressure treatment dressing 118. - After the
moist barrier 116 is deployed at the desired location, e.g., thewound edges pressure treatment dressing 118 is placed over thetissue site 102 and themoist barrier 116, the sealingmember 120 is deployed. The sealingmember 120 is deployed over the reduced-pressure treatment dressing 118 and a portion of a patient'sintact epidermis 112. - The sealing
member 120 has afirst side 121 and a second, tissue-facingside 123. The sealingmember 120 may be formed from any material that provides a fluid seal. “Fluid seal,” or “seal,” means a seal adequate to maintain reduced pressure at a desired site given the particular reduced-pressure source or subsystem involved. The sealing member may, for example, be an impermeable or semi-permeable, elastomeric material. “Elastomeric” means having the properties of an elastomer. Elastomer generally refers to a polymeric material that has rubber-like properties. More specifically, most elastomers typically have ultimate elongations greater than 100% and a significant amount of resilience. The resilience of a material refers to the material's ability to recover from an elastic deformation. Examples of elastomers may include, but are not limited to, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane, EVA film, co-polyester, and silicones. Additional examples of sealing member materials include a silicone drape, 3M Tegaderm® drape, polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif. - An
attachment device 122 may be used to form a fluid seal between theepidermis 112 and thesealing member 120. Theattachment device 122 may be used to hold the sealingmember 120 against the patient'sepidermis 112 or another layer, such as a gasket or additional sealing member. Theattachment device 122 may take numerous forms. For example, theattachment device 122 may be a medically acceptable, pressure-sensitive adhesive 124 that extends about a periphery of the sealingmember 120. - The reduced-pressure treatment dressing 118, which has a
first side 130 and a second, tissue-facingside 132, may be any dressing that distributes reduced pressure and that may help promote micro-strain at thetissue site 102. For example, the reduced-pressure treatment dressing 118 may be or include themanifold 128. The term “manifold” as used herein generally refers to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from thetissue site 102. The manifold 128 typically includes a plurality of flow channels or pathways that distribute fluids provided to and removed from thetissue site 102 around themanifold 128. In one illustrative, non-limiting embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided or removed from thetissue site 102. The manifold 128 may be a biocompatible material that is capable of being placed in contact with thetissue site 102 and distributing reduced pressure to thetissue site 102. - Examples of the manifold 128 may include, for example, without limitation, devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels. The manifold 128 may be porous and may be made from foam, gauze, felted mat, or any other material suited to a particular biological application. In one embodiment, the manifold 128 is a porous foam and includes a plurality of interconnected cells or pores that act as flow channels. The porous foam may be a polyurethane, open-cell, reticulated foam, such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Tex. Other embodiments may include “closed cells.” The manifold 128 has a
first side 129 and a second, tissue-facingside 131. The second, tissue-facingside 131 may provide a micro-strain-inducing surface, such as open cells or protrusions or other devices that impinge on thetissue site 102 when under reduced pressure or a force. - In one embodiment, the manifold 128 may be constructed from bioresorbable materials that do not have to be removed from a patient's body following use of the reduced-pressure treatment dressing 118. Suitable bioresorbable materials may include, without limitation, a polymeric blend of polylactic acid (PLA) and polyglycolic acid (PGA). The polymeric blend may also include without limitation polycarbonates, polyfumarates, and capralactones. The manifold 128 may further serve as a scaffold for new cell-growth, or a scaffold material may be used in conjunction with the manifold 128 to promote cell-growth. A scaffold is a substance or structure used to enhance or promote the growth of cells or formation of tissue, such as a three-dimensional porous structure that provides a template for cell growth. Illustrative examples of scaffold materials include calcium phosphate, collagen, PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft materials.
- In some situations, the manifold 128 may also be used to distribute fluids, such as medications, antibacterials, growth factors, and various solutions to the
tissue site 102. Other layers may be included in or on the manifold 128, such as absorptive materials, wicking materials, hydrophobic materials, and hydrophilic materials. - A reduced-
pressure connector 134 may be associated with the reduced-pressure treatment dressing 118 to provide reduced pressure thereto. The reduced-pressure connector 134 may have aflange portion 136 that may be disposed between the sealingmember 120 and thefirst side 130 of the reduced-pressure treatment dressing 118. A portion of the reduced-pressure connector 134 extends through aconnector aperture 138 in the sealingmember 120. A reducedpressure delivery conduit 140 may be used to fluidly couple the reduced-pressure connector 134 to a reduced-pressure source 142. One ormore devices 144 may be associated or fluidly coupled to the reduced-pressure delivery conduit 140. The device ordevices 144 that may be fluidly coupled to the reduced-pressure delivery conduit 140 include, for example, without limitation, a fluid reservoir or collection member to hold exudates and other fluids removed, a pressure-feedback device, a volume detection system, a blood detection system, an infection detection system, a flow monitoring system, a temperature monitoring system, or other device. - The reduced-
pressure source 142 provides reduced pressure as a part of thesystem 100. The term “reduced pressure” as used herein generally refers to a pressure less than the ambient pressure at a tissue site that is being subjected to treatment. In most cases, this reduced pressure will be less than the atmospheric pressure at which the patient is located. Alternatively, the reduced pressure may be less than a hydrostatic pressure of tissue at the tissue site. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to the tissue site, the actual pressure applied to the tissue site may be significantly more than the pressure normally associated with a complete vacuum. Unless otherwise indicated, values of pressure stated herein are gauge pressures. - The reduced pressure delivered by the reduced-
pressure source 142 may be constant or varied (patterned or random) and may be delivered continuously or intermittently. In order to maximize patient mobility and ease, the reduced-pressure source 142 may be a battery-powered, reduced-pressure generator. This facilitates application in the operating room and provides mobility and convenience for the patient during the rehabilitation phase. Other sources of reduced pressure might be utilized, such as V.A.C.® therapy unit, which is available from KCI of San Antonio, Tex., wall suction, a mechanical unit, or a micro-pump imbedded in the reduced-pressure treatment dressing 118. The pressure may in the range of −5 mm Hg to −500 mm Hg and more typically between −100 mm Hg and −200 mm Hg. - The reduced pressure developed by the reduced-
pressure source 142 is delivered through the reduced-pressure delivery conduit 140, or medical conduit or tubing, to the reduced-pressure connector 134. A hydrophobic membrane filter may be interspersed between the reduced-pressure delivery conduit 140 and the reduced-pressure source 142. In another illustrative embodiment, reduced pressure is delivered by a micro-pump to a sealed spaced under the sealingmember 120. - The
moist barrier 116 may be formed from numerous materials. In one illustrative, non-limiting embodiment, themoist barrier 116 is a moist, water-sensitive barrier, such as a hydrogel, hydrocolloid, or other part solid solution. Themoist barrier 116 may also be a substance in a foam formulation such as a hydrogel or hydrocolloid foam form or may be an emulsified oil. The material from which themoist barrier 116 is formed may be water-sensitive, or a fluid balancing material, meaning that the material will provide moisture to dry wounds and will absorb moisture from excessively moist, or wet, wounds. In one illustrative, non-limiting embodiment, themoist barrier 116 may be a water-sensitive,flowable material 146, such as a flowable hydrogel or flowable hydrocolloid. Themoist barrier 116 may include additional substances, such as growth factors. Themoist barrier 116 may promote bio-mimicry. - The water-sensitive,
flowable material 146 may be a high viscosity fluid, like a flowable hydrogel or hydrocolloid that is low enough in viscosity to flow, but high enough in viscosity to occlude the reduced-pressure treatment dressing 118. The water-sensitive,flowable material 146 may move partially into themanifold 128. The degree to which the water-sensitive,flowable material 146 moves into the manifold 128 is, in the case of a foam manifold, governed primarily by pore size, the level of reduced pressure, and the viscosity of the water-sensitive,flowable material 146. For example, with a relatively viscous embodiment of the water-sensitive,flowable material 146 against a fine pore size foam, a majority of the water-sensitive,flowable material 146 will remain at the interface of the water-sensitive,flowable material 146 and the foam. - As an illustrative, non-limiting example, the water-sensitive,
flowable material 146 may have a viscosity in the range of 2,000 to 250,000 centipoise (cP) at 25° C. As another illustrative, non-limiting example, the water-sensitive,flowable material 146 may have a viscosity in the range of 50,000 to 150,000 cP at 25° C. In another illustrative, embodiment, the water-sensitive,flowable material 146 may be a gel that is pseudoplastic (capable of shear thinning, i.e., shear dependent viscosity) so that the material has a low viscosity as dispensed with high shear, but once in place with a low shear situation, the material increases in viscosity. - The
moist barrier 116 is typically deployed in a position to cover the wound edges 106, 110 and may be deployed in a number of ways. Referring now primarily toFIG. 2 , one illustrative, non-limiting description of a process for forming themoist barrier 116 is presented. In this illustrative example, themoist barrier 116 comprises the water-sensitive,flowable material 146. Adelivery device 150, such as a squirtable container of material, asyringe 152, or other device, is used to deliver the water-sensitive,flowable material 146 directly to portions of thetissue site 102 where granulation is not desired, but re-epithelialization is desired. In this way, themoist barrier 116 is formed in situ. The water-sensitive,flowable material 146 may provide a moist environment for the portions of thetissue site 102 that are covered by the water-sensitive,flowable material 146, and the water-sensitive,flowable material 146 restricts or prevents reduced pressure from being delivered through the reduced-pressure treatment dressing 118 to the covered tissue or otherwise prevents micro-strain from being induced at the covered locations. In the illustrative example in which the reduced-pressure treatment dressing 118 is formed from an open cell foam, the water-sensitive,flowable material 146 may occlude cells that contact the water-sensitive,flowable material 146. - Referring now primarily to
FIG. 3 , another illustrative, non-limiting example of how themoist barrier 116 may be formed is presented. In this illustrative, non-limiting embodiment, thedelivery device 150, e.g., thesyringe 152, is used to apply a water-sensitive,flowable material 146 onto the second, tissue-facingside 131 of themanifold 128. The water-sensitive,flowable material 146 is applied at locations on the second, tissue-facingside 131 of the manifold 128 that correspond or align, when deployed, with the portions of thetissue site 102 where granulation is not desired and re-epithelialization is desired. Thus, once the water-sensitive,flowable material 146 is applied to the second, tissue-facingside 131 of the manifold 128 and the manifold 128 is deployed adjacent to thetissue site 102, only the desired portions of thetissue site 102 will receive reduced pressure in operation. - Referring now primarily to
FIG. 4 , still another illustrative, non-limiting example of how themoist barrier 116 may be formed is presented. In this illustrative example, alayer 154 of water-sensitive material is applied to the second, tissue-facingside 131 of the manifold 128 and substantially covers the second, tissue-facingside 131 of themanifold 128. Thelayer 154 includes perforations orcuts 156 that readily allow one to remove one or more segments, orportions 158, of thelayer 154 to expose a portion of the second, tissue-facingside 131 of themanifold 128. As such, thesegments 158 may be removed that correspond, when deployed, to portions of thetissue site 102 where granulation is desired. When the reduced-pressure treatment dressing 118 is deployed with the second, tissue-facingside 131 adjacent thetissue site 102, the remaining portions of thelayer 154 that form themoist barrier 116 will be adjacent to the areas where no granulation is desired but re-epthiliazation is desired. At the same time, the second, tissue-facingside 131 of the manifold 128 will be against the portions of thetissue site 102 where granulation is desired. - According to one illustrative, non-limiting embodiment, the
moist barrier 116 may be formed from a hydrogel, hydrocolloid, or other material. In this embodiment, the hydrogel or hydrocolloid may be cast onto a woven liner and cross-linked. In this illustrative embodiment, the hydrogrel or hydrocolloid is not mobile. - According to one illustrative, non-limiting method of deploying the
wound treatment system 100, themoist barrier 116 is placed adjacent to the portion of thetissue site 102 where granulation is not desired and where re-epithelialization is desired. The second, tissue-facingside 131 of the manifold 128 is placed directly adjacent to the portion of thetissue site 102 where granulation is desired. The sealingmember 120 is placed over thetissue site 102 and a portion of the patient'sintact epidermis 112 to form a fluid seal. Reduced pressure is supplied to themanifold 128. - A kit for deploying a dressing for promoting granulation and re-epithelialization of a wound of a patient may be formed that provides an easy and convenient manner to treat a wound. The kit may include a reduced-pressure treatment dressing (e.g., reduced-pressure treatment dressing 118) and a water-sensitive, flowable material (e.g., water-sensitive, flowable material 146) for disposing adjacent to the reduced-pressure treatment dressing (e.g., reduced-pressure dressing 118) at locations on the wound where granulation is not desired and where re-epithelialization is desired. The kit also may include a sealing member (e.g., sealing member 120) for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient and may include a reduced-pressure delivery conduit (e.g., reduced-pressure delivery conduit 140) for providing reduced pressure to the reduced-pressure treatment dressings. The kit may include a delivery device (e.g., delivery device 150) for applying the water-sensitive, flowable material and may include a reduced-pressure connector (e.g., reduced-pressure connector 134).
- Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in a connection to any one embodiment may also be applicable to any other embodiment.
Claims (21)
1. A method for promoting granulation and re-epithelialization of a wound of a patient, the method comprising the steps of:
providing a reduced-pressure treatment dressing having a first side and a second, tissue-facing side, wherein the second, tissue-facing side has a micro-strain inducing surface;
creating a moist, water-sensitive barrier on at least a portion of the wound to promote re-epithelialization and to inhibit granulation;
placing the reduced-pressure treatment dressing over a peri-wound area such that the reduced-pressure treatment dressing covers at least a portion of the wound and at least
a portion of the moist, water-sensitive barrier;
forming a fluid seal over the reduced-pressure treatment dressing and a portion of epidermis of the patient; and
applying reduced pressure to the reduced-pressure treatment dressing.
2. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the step of creating a moist, water-sensitive barrier comprises the step of creating a moist, water-sensitive barrier over wound edges of the wound.
3. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the step of creating a moist, water-sensitive barrier comprises the step of deploying a water-sensitive, flowable material.
4. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the step of creating a moist, water-sensitive barrier comprises the step of deploying a water-sensitive, flowable material on the at least a portion of the wound to promote re-epithelialization and to inhibit granulation; and wherein the water-sensitive, flowable material has a viscosity in the range of 50,000 to 150,000 cP at 25° C.
5. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the reduced-pressure treatment dressing comprises a layer of removable, moist water-sensitive barrier material on a manifold, and wherein the step of creating a moist, water-sensitive barrier comprises the steps of removing a portion of the removable, moist water-sensitive barrier material from the manifold at a location to promote granulation on a portion of the wound.
6. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the micro-strain inducing surface is an open-cell foam.
7. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the step of creating a moist, water-sensitive barrier comprises the step of deploying a water-sensitive, flowable material to inhibit granulation and to promote re-epithelialization; and wherein the water-sensitive, flowable material is a hydrogel.
8. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein:
creating a moist, water-sensitive barrier comprises deploying a water-sensitive, flowable material to align with locations to inhibit granulation and to promote re-epithelialization;
the water-sensitive, flowable material comprises a hydrogel having a viscosity in the range of 50,000 to 150,000 cP at 25° C.;
deploying a water-sensitive, flowable material comprises using a syringe to deliver the water-sensitive, flowable material onto the micro-strain inducing surface on portions that will interface with tissue to promote re-epithelialization and to inhibit granulation.
9. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein the step of deploying a water-sensitive, flowable material comprises using a syringe to deliver the water-sensitive, flowable material onto the micro-strain inducing surface on portions that will interface with tissue where re-epithelialization is desired and granulation is not desired.
10. The method for promoting granulation and re-epithelialization of a wound of claim 1 , wherein:
the step of creating a moist, water-sensitive barrier comprises the step of deploying a water-sensitive, flowable material to align with locations where granulation is not desired;
the water-sensitive, flowable material comprises a hydrogel; and
the step of deploying a water-sensitive, flowable material comprises using a delivery device to deliver the water-sensitive, flowable material onto tissue where re-epithelialization and not granulation is desired.
11. A system for promoting granulation and re-epithelialization of a wound of a patient, the system comprising:
a reduced-pressure treatment dressing having a first side and a second, tissue-facing side, wherein the second, tissue-facing side has a micro-strain inducing surface;
a moist, water-sensitive barrier disposed adjacent to the reduced-pressure treatment dressing at locations to promote re-epithelialization and to inhibit granulation;
a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient; and
a reduced-pressure source for providing reduced pressure to the reduced-pressure treatment dressing.
12. The system of claim 11 , wherein the moist, water-sensitive barrier comprises a water-sensitive, flowable material aligned with portions of the wound to promote re-epithelialization and to inhibit granulation.
13. The system of claim 11 , wherein the moist, water-sensitive barrier comprises a water-sensitive, flowable material aligned with portions of the wound to promote re-epithelialization and to inhibit granulation, and wherein the water-sensitive, flowable material is a hydrogel.
14. The system of claim 11 , wherein the reduced-pressure treatment dressing comprises a layer of removable, moist water-sensitive barrier on a manifold, and wherein the removable, moist water-sensitive barrier is absent on portions of the manifold on a tissue-facing surface to promote granulation.
15. The system of claim 11 , wherein the micro-strain inducing surface is an open-cell foam.
16. The system of claim 11 , wherein the micro-strain inducing surface is a gauze.
17. A kit for deploying a dressing for promoting granulation and re-epithelialization of a wound of a patient, the kit comprising:
a reduced-pressure treatment dressing having a first side and a second, tissue-facing side, wherein the second, tissue-facing side has a micro-strain inducing surface;
a water-sensitive, flowable material for disposing adjacent to the reduced-pressure treatment dressing and adjacent to portions of the wound to promote re-epithelialization and to inhibit granulation;
a sealing member for placing over the reduced-pressure treatment dressing and a portion of epidermis of the patient; and
a delivery device for applying the water-sensitive, flowable material.
18. The kit of claim 17 , wherein delivery device comprises a syringe.
19. The kit of claim 17 , wherein the water-sensitive, flowable material comprises a flowable hydrogel and the delivery device comprises a syringe.
20. The kit of claim 17 , wherein the water-sensitive, flowable material comprises a flowable hydrogel; the delivery device comprises a syringe; and wherein the flowable hydrogel has a viscosity in the range of 50,000 to 150,000 cP at 25° C.
21. The kit of claim 17 , further comprising a reduced-pressure delivery conduit for providing reduced pressure to the reduced-pressure treatment dressings.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/857,179 US20110054420A1 (en) | 2009-08-27 | 2010-08-16 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
US14/135,120 US10064759B2 (en) | 2009-08-27 | 2013-12-19 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23750409P | 2009-08-27 | 2009-08-27 | |
US12/857,179 US20110054420A1 (en) | 2009-08-27 | 2010-08-16 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/135,120 Division US10064759B2 (en) | 2009-08-27 | 2013-12-19 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110054420A1 true US20110054420A1 (en) | 2011-03-03 |
Family
ID=43625925
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/857,179 Abandoned US20110054420A1 (en) | 2009-08-27 | 2010-08-16 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
US14/135,120 Active 2030-10-29 US10064759B2 (en) | 2009-08-27 | 2013-12-19 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/135,120 Active 2030-10-29 US10064759B2 (en) | 2009-08-27 | 2013-12-19 | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Country Status (1)
Country | Link |
---|---|
US (2) | US20110054420A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110125113A1 (en) * | 2008-06-23 | 2011-05-26 | Carmeli Adahan | Tissue enclosure |
US20170348154A1 (en) * | 2011-06-24 | 2017-12-07 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
Citations (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2547758A (en) * | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) * | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
US2682873A (en) * | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
US2969057A (en) * | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3367332A (en) * | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) * | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) * | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3648692A (en) * | 1970-12-07 | 1972-03-14 | Parke Davis & Co | Medical-surgical dressing for burns and the like |
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
US3826254A (en) * | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4096853A (en) * | 1975-06-21 | 1978-06-27 | Hoechst Aktiengesellschaft | Device for the introduction of contrast medium into an anus praeter |
US4139004A (en) * | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4165748A (en) * | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4184510A (en) * | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4245630A (en) * | 1976-10-08 | 1981-01-20 | T. J. Smith & Nephew, Ltd. | Tearable composite strip of materials |
US4256109A (en) * | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
US4261363A (en) * | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4275721A (en) * | 1978-11-28 | 1981-06-30 | Landstingens Inkopscentral Lic, Ekonomisk Forening | Vein catheter bandage |
US4284079A (en) * | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4333468A (en) * | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4382441A (en) * | 1978-12-06 | 1983-05-10 | Svedman Paul | Device for treating tissues, for example skin |
US4392858A (en) * | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4392853A (en) * | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4465485A (en) * | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4525166A (en) * | 1981-11-21 | 1985-06-25 | Intermedicat Gmbh | Rolled flexible medical suction drainage device |
US4525374A (en) * | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
US4569348A (en) * | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4605399A (en) * | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US4608041A (en) * | 1981-10-14 | 1986-08-26 | Frese Nielsen | Device for treatment of wounds in body tissue of patients by exposure to jets of gas |
US4640688A (en) * | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4664662A (en) * | 1984-08-02 | 1987-05-12 | Smith And Nephew Associated Companies Plc | Wound dressing |
US4733659A (en) * | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
US4743232A (en) * | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
US4758220A (en) * | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4826494A (en) * | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4838883A (en) * | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
US4840187A (en) * | 1986-09-11 | 1989-06-20 | Bard Limited | Sheath applicator |
US4897081A (en) * | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US4906233A (en) * | 1986-05-29 | 1990-03-06 | Terumo Kabushiki Kaisha | Method of securing a catheter body to a human skin surface |
US4906240A (en) * | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4919654A (en) * | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US4941882A (en) * | 1987-03-14 | 1990-07-17 | Smith And Nephew Associated Companies, P.L.C. | Adhesive dressing for retaining a cannula on the skin |
US4985019A (en) * | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
US5018515A (en) * | 1987-12-14 | 1991-05-28 | The Kendall Company | See through absorbent dressing |
US5037397A (en) * | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US5086170A (en) * | 1989-01-16 | 1992-02-04 | Roussel Uclaf | Process for the preparation of azabicyclo compounds |
US5092858A (en) * | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5100396A (en) * | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5106629A (en) * | 1989-10-20 | 1992-04-21 | Ndm Acquisition Corp. | Transparent hydrogel wound dressing |
US5134994A (en) * | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5160315A (en) * | 1991-04-05 | 1992-11-03 | Minnesota Mining And Manufacturing Company | Combined adhesive strip and transparent dressing delivery system |
US5176663A (en) * | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US5215522A (en) * | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
US5278100A (en) * | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5279550A (en) * | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5298015A (en) * | 1989-07-11 | 1994-03-29 | Nippon Zeon Co., Ltd. | Wound dressing having a porous structure |
US5356372A (en) * | 1993-12-01 | 1994-10-18 | Ludlow Corporation | Occlusive pressure-reducing wound dressing |
US5423737A (en) * | 1993-05-27 | 1995-06-13 | New Dimensions In Medicine, Inc. | Transparent hydrogel wound dressing with release tab |
US5437651A (en) * | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5527293A (en) * | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5607388A (en) * | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5645081A (en) * | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5844013A (en) * | 1992-10-02 | 1998-12-01 | Beiersdorf Ag | Hydrophilic polyurethane gel foams, particularly for treating deep wounds, wound dressing based on hydrophilic polyurethane gel foams and method of manufacture |
US6071267A (en) * | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6201164B1 (en) * | 1996-07-11 | 2001-03-13 | Coloplast A/S | Hydrocolloid wound gel |
US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US20010043943A1 (en) * | 2000-05-22 | 2001-11-22 | Coffey Arthur C. | Combination SIS and vacuum bandage and method |
US6345623B1 (en) * | 1997-09-12 | 2002-02-12 | Keith Patrick Heaton | Surgical drape and suction head for wound treatment |
US20020077661A1 (en) * | 2000-12-20 | 2002-06-20 | Vahid Saadat | Multi-barbed device for retaining tissue in apposition and methods of use |
US6420622B1 (en) * | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US20020132540A1 (en) * | 2000-12-29 | 2002-09-19 | Dave Soerens | Absorbent, lubricious coating and articles coated therewith |
US6566575B1 (en) * | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
US20030203011A1 (en) * | 2002-04-12 | 2003-10-30 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
US20030232905A1 (en) * | 2000-04-06 | 2003-12-18 | Ives Christopher L. | Pressure sensitive adhesive compositions |
US6685681B2 (en) * | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US20040030304A1 (en) * | 2000-05-09 | 2004-02-12 | Kenneth Hunt | Abdominal wound dressing |
US20040243073A1 (en) * | 2001-12-26 | 2004-12-02 | Lockwood Jeffrey S. | Wound vacuum therapy dressing kit |
US20050037194A1 (en) * | 2003-08-15 | 2005-02-17 | Kimberly-Clark Worldwide, Inc. | Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same |
US20050064021A1 (en) * | 2001-11-20 | 2005-03-24 | Rippon Mark Geoffrey | Medical dressings |
US20050085795A1 (en) * | 2002-02-28 | 2005-04-21 | Lockwood Jeffrey S. | External catheter access to vacuum bandage |
US20050137539A1 (en) * | 2002-09-13 | 2005-06-23 | Biggie John J. | Closed wound drainage system |
US20050228329A1 (en) * | 2004-04-13 | 2005-10-13 | Boehringer John R | Wound contact device |
US20060041247A1 (en) * | 2002-08-21 | 2006-02-23 | Robert Petrosenko | Wound packing for preventing wound closure |
US7004915B2 (en) * | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
US7070584B2 (en) * | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US20060155260A1 (en) * | 2002-10-28 | 2006-07-13 | Blott Patrick L | Apparatus for aspirating, irrigating and cleansing wounds |
US20060173253A1 (en) * | 1999-04-06 | 2006-08-03 | Kci Licensing, Inc. | Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system |
US20060189910A1 (en) * | 2001-02-16 | 2006-08-24 | Kci Licensing, Inc. | Biocompatible wound dressing |
US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
US20070055209A1 (en) * | 2005-09-07 | 2007-03-08 | Patel Harish A | Self contained wound dressing apparatus |
US20070185426A1 (en) * | 2001-02-16 | 2007-08-09 | Kci Licensing, Inc. | Biocompatible wound dressing |
US20070219532A1 (en) * | 2005-07-14 | 2007-09-20 | Boehringer Technologies, Lp | Pump system for negative pressure wound therapy |
US20080011368A1 (en) * | 2006-04-25 | 2008-01-17 | Singh Vinay K | Inline swivel connection for multi-lumen tubing |
US20080039763A1 (en) * | 2002-12-31 | 2008-02-14 | Sigurjonsson Gudmundur F | Wound dressing |
US20080076844A1 (en) * | 2006-09-22 | 2008-03-27 | The Dow Chemical Company | Fibrillated polyolefin foam |
US20080215020A1 (en) * | 2007-01-22 | 2008-09-04 | Reeves William H | Apparatuses and methods for healing wounds |
US20080300555A1 (en) * | 2007-05-10 | 2008-12-04 | Olson Jonathan S | Reduced pressure wound dressing having a wound contact surface with columnar protrusions |
US20090043268A1 (en) * | 2007-08-06 | 2009-02-12 | Eddy Patrick E | Wound treatment system and suction regulator for use therewith |
US20090254066A1 (en) * | 2006-10-13 | 2009-10-08 | Keith Patrick Heaton | Reduced pressure indicator for a reduced pressure source |
US20090275922A1 (en) * | 2008-05-02 | 2009-11-05 | Richard Daniel John Coulthard | Manually-actuated reduced pressure treatment system having regulated pressure capabilities |
US20090306630A1 (en) * | 2008-06-04 | 2009-12-10 | Christopher Brian Locke | Reduced-pressure, liquid-collection canister with multi-orientation filter |
US7651484B2 (en) * | 2006-02-06 | 2010-01-26 | Kci Licensing, Inc. | Systems and methods for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems |
US20100125258A1 (en) * | 2008-11-14 | 2010-05-20 | Richard Daniel John Coulthard | Fluid pouch, system, and method for storing fluid from a tissue site |
US20110230848A1 (en) * | 2010-03-16 | 2011-09-22 | Michael Manwaring | Epithelialization methods, dressings, and systems |
US20110288512A1 (en) * | 2010-05-18 | 2011-11-24 | Christopher Brian Locke | Reduced-pressure medical systems and methods employing a moisture processing device |
US20120016323A1 (en) * | 2010-07-19 | 2012-01-19 | Kci Licensing, Inc. | Inflatable off-loading wound dressing assemblies, systems, and methods |
US20120046624A1 (en) * | 2010-08-18 | 2012-02-23 | Christopher Brian Locke | Reduced-pressure, multi-orientation, liquid-collection canister |
US8172816B2 (en) * | 2008-05-30 | 2012-05-08 | Kci Licensing, Inc. | Anisotropic drapes and systems |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
ATE14835T1 (en) | 1980-03-11 | 1985-08-15 | Schmid Eduard | SKIN GRAFT PRESSURE BANDAGE. |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
JP2941918B2 (en) | 1990-09-19 | 1999-08-30 | テルモ株式会社 | Weighing device |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
ES2223977T3 (en) | 1994-08-22 | 2005-03-01 | Kci Licensing, Inc. | CONTAINER. |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
TR200401397T4 (en) | 2000-02-24 | 2004-07-21 | Venetec International, Inc. | Universal catheter insertion system. |
US6855135B2 (en) * | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
US6838589B2 (en) * | 2003-02-19 | 2005-01-04 | 3M Innovative Properties Company | Conformable wound dressing |
CN102137688B (en) * | 2008-09-18 | 2014-01-22 | 凯希特许有限公司 | Therapy delivery systems and methods |
-
2010
- 2010-08-16 US US12/857,179 patent/US20110054420A1/en not_active Abandoned
-
2013
- 2013-12-19 US US14/135,120 patent/US10064759B2/en active Active
Patent Citations (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2547758A (en) * | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) * | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
US2682873A (en) * | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
US2969057A (en) * | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3367332A (en) * | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) * | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) * | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
US3648692A (en) * | 1970-12-07 | 1972-03-14 | Parke Davis & Co | Medical-surgical dressing for burns and the like |
US3826254A (en) * | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US4096853A (en) * | 1975-06-21 | 1978-06-27 | Hoechst Aktiengesellschaft | Device for the introduction of contrast medium into an anus praeter |
US4245630A (en) * | 1976-10-08 | 1981-01-20 | T. J. Smith & Nephew, Ltd. | Tearable composite strip of materials |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) * | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) * | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) * | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4256109A (en) * | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
US4275721A (en) * | 1978-11-28 | 1981-06-30 | Landstingens Inkopscentral Lic, Ekonomisk Forening | Vein catheter bandage |
US4382441A (en) * | 1978-12-06 | 1983-05-10 | Svedman Paul | Device for treating tissues, for example skin |
US4284079A (en) * | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) * | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) * | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4333468A (en) * | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) * | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) * | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) * | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) * | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4608041A (en) * | 1981-10-14 | 1986-08-26 | Frese Nielsen | Device for treatment of wounds in body tissue of patients by exposure to jets of gas |
US4525166A (en) * | 1981-11-21 | 1985-06-25 | Intermedicat Gmbh | Rolled flexible medical suction drainage device |
US4525374A (en) * | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
US4897081A (en) * | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) * | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
US4664662A (en) * | 1984-08-02 | 1987-05-12 | Smith And Nephew Associated Companies Plc | Wound dressing |
US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) * | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) * | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) * | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) * | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4758220A (en) * | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) * | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
US4838883A (en) * | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
US4906233A (en) * | 1986-05-29 | 1990-03-06 | Terumo Kabushiki Kaisha | Method of securing a catheter body to a human skin surface |
US4840187A (en) * | 1986-09-11 | 1989-06-20 | Bard Limited | Sheath applicator |
US4743232A (en) * | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
US4941882A (en) * | 1987-03-14 | 1990-07-17 | Smith And Nephew Associated Companies, P.L.C. | Adhesive dressing for retaining a cannula on the skin |
US5176663A (en) * | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US5018515A (en) * | 1987-12-14 | 1991-05-28 | The Kendall Company | See through absorbent dressing |
US4906240A (en) * | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) * | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
US4919654A (en) * | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5086170A (en) * | 1989-01-16 | 1992-02-04 | Roussel Uclaf | Process for the preparation of azabicyclo compounds |
US5100396A (en) * | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5527293A (en) * | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5298015A (en) * | 1989-07-11 | 1994-03-29 | Nippon Zeon Co., Ltd. | Wound dressing having a porous structure |
US5106629A (en) * | 1989-10-20 | 1992-04-21 | Ndm Acquisition Corp. | Transparent hydrogel wound dressing |
US5134994A (en) * | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) * | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5160315A (en) * | 1991-04-05 | 1992-11-03 | Minnesota Mining And Manufacturing Company | Combined adhesive strip and transparent dressing delivery system |
US5278100A (en) * | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5645081A (en) * | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5279550A (en) * | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5844013A (en) * | 1992-10-02 | 1998-12-01 | Beiersdorf Ag | Hydrophilic polyurethane gel foams, particularly for treating deep wounds, wound dressing based on hydrophilic polyurethane gel foams and method of manufacture |
US6241747B1 (en) * | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5489262A (en) * | 1993-05-27 | 1996-02-06 | New Dimensions In Medicine, Inc. | Transparent hydrogel wound dressing with release tab |
US5423737A (en) * | 1993-05-27 | 1995-06-13 | New Dimensions In Medicine, Inc. | Transparent hydrogel wound dressing with release tab |
US5437651A (en) * | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5356372A (en) * | 1993-12-01 | 1994-10-18 | Ludlow Corporation | Occlusive pressure-reducing wound dressing |
US5607388A (en) * | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US20060264796A1 (en) * | 1995-09-05 | 2006-11-23 | Argentum Medical, Llc | Medical device |
US6201164B1 (en) * | 1996-07-11 | 2001-03-13 | Coloplast A/S | Hydrocolloid wound gel |
US6420622B1 (en) * | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US20020128578A1 (en) * | 1997-08-01 | 2002-09-12 | 3M Innovative Properties Company | Medical article having fluid control film |
US6345623B1 (en) * | 1997-09-12 | 2002-02-12 | Keith Patrick Heaton | Surgical drape and suction head for wound treatment |
US6814079B2 (en) * | 1997-09-12 | 2004-11-09 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6553998B2 (en) * | 1997-09-12 | 2003-04-29 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6071267A (en) * | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US20060173253A1 (en) * | 1999-04-06 | 2006-08-03 | Kci Licensing, Inc. | Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system |
US20110196284A1 (en) * | 1999-04-06 | 2011-08-11 | Premnarayan Ganapathy | Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system |
US7947033B2 (en) * | 1999-04-06 | 2011-05-24 | Kci Licensing Inc. | Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system |
US6566575B1 (en) * | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
US20030232905A1 (en) * | 2000-04-06 | 2003-12-18 | Ives Christopher L. | Pressure sensitive adhesive compositions |
US20080243044A1 (en) * | 2000-05-09 | 2008-10-02 | Kenneth Hunt | Abdominal wound dressing |
US20040030304A1 (en) * | 2000-05-09 | 2004-02-12 | Kenneth Hunt | Abdominal wound dressing |
US20010043943A1 (en) * | 2000-05-22 | 2001-11-22 | Coffey Arthur C. | Combination SIS and vacuum bandage and method |
US6752794B2 (en) * | 2000-11-29 | 2004-06-22 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US20040064111A1 (en) * | 2000-11-29 | 2004-04-01 | Lockwood Jeffrey S. | Vacuum therapy and cleansing dressing for wounds |
US6685681B2 (en) * | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US20020077661A1 (en) * | 2000-12-20 | 2002-06-20 | Vahid Saadat | Multi-barbed device for retaining tissue in apposition and methods of use |
US20020132540A1 (en) * | 2000-12-29 | 2002-09-19 | Dave Soerens | Absorbent, lubricious coating and articles coated therewith |
US20070185426A1 (en) * | 2001-02-16 | 2007-08-09 | Kci Licensing, Inc. | Biocompatible wound dressing |
US20060189910A1 (en) * | 2001-02-16 | 2006-08-24 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7070584B2 (en) * | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7004915B2 (en) * | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
US20050064021A1 (en) * | 2001-11-20 | 2005-03-24 | Rippon Mark Geoffrey | Medical dressings |
US20040243073A1 (en) * | 2001-12-26 | 2004-12-02 | Lockwood Jeffrey S. | Wound vacuum therapy dressing kit |
US20050085795A1 (en) * | 2002-02-28 | 2005-04-21 | Lockwood Jeffrey S. | External catheter access to vacuum bandage |
US20060039982A1 (en) * | 2002-04-12 | 2006-02-23 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
US20030203011A1 (en) * | 2002-04-12 | 2003-10-30 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
US20060041247A1 (en) * | 2002-08-21 | 2006-02-23 | Robert Petrosenko | Wound packing for preventing wound closure |
US7520872B2 (en) * | 2002-09-13 | 2009-04-21 | Neogen Technologies, Inc. | Closed wound drainage system |
US20050137539A1 (en) * | 2002-09-13 | 2005-06-23 | Biggie John J. | Closed wound drainage system |
US20060155260A1 (en) * | 2002-10-28 | 2006-07-13 | Blott Patrick L | Apparatus for aspirating, irrigating and cleansing wounds |
US20080039763A1 (en) * | 2002-12-31 | 2008-02-14 | Sigurjonsson Gudmundur F | Wound dressing |
US20050037194A1 (en) * | 2003-08-15 | 2005-02-17 | Kimberly-Clark Worldwide, Inc. | Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same |
US20050228329A1 (en) * | 2004-04-13 | 2005-10-13 | Boehringer John R | Wound contact device |
US20070219532A1 (en) * | 2005-07-14 | 2007-09-20 | Boehringer Technologies, Lp | Pump system for negative pressure wound therapy |
US20070055209A1 (en) * | 2005-09-07 | 2007-03-08 | Patel Harish A | Self contained wound dressing apparatus |
US20100106118A1 (en) * | 2006-02-06 | 2010-04-29 | Keith Patrick Heaton | Systems and methods for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems |
US7651484B2 (en) * | 2006-02-06 | 2010-01-26 | Kci Licensing, Inc. | Systems and methods for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems |
US8002313B2 (en) * | 2006-04-25 | 2011-08-23 | Kci Licensing, Inc. | Inline swivel connection for multi-lumen tubing |
US20110301557A1 (en) * | 2006-04-25 | 2011-12-08 | Kci Licensing, Inc. | Inline swivel connection for multi-lumen tubing |
US20080011368A1 (en) * | 2006-04-25 | 2008-01-17 | Singh Vinay K | Inline swivel connection for multi-lumen tubing |
US20080076844A1 (en) * | 2006-09-22 | 2008-03-27 | The Dow Chemical Company | Fibrillated polyolefin foam |
US20090254066A1 (en) * | 2006-10-13 | 2009-10-08 | Keith Patrick Heaton | Reduced pressure indicator for a reduced pressure source |
US20080215020A1 (en) * | 2007-01-22 | 2008-09-04 | Reeves William H | Apparatuses and methods for healing wounds |
US20080300555A1 (en) * | 2007-05-10 | 2008-12-04 | Olson Jonathan S | Reduced pressure wound dressing having a wound contact surface with columnar protrusions |
US8057447B2 (en) * | 2007-05-10 | 2011-11-15 | Kci Licensing Inc. | Reduced pressure wound dressing having a wound contact surface with columnar protrusions |
US20090043268A1 (en) * | 2007-08-06 | 2009-02-12 | Eddy Patrick E | Wound treatment system and suction regulator for use therewith |
US20090275922A1 (en) * | 2008-05-02 | 2009-11-05 | Richard Daniel John Coulthard | Manually-actuated reduced pressure treatment system having regulated pressure capabilities |
US8172816B2 (en) * | 2008-05-30 | 2012-05-08 | Kci Licensing, Inc. | Anisotropic drapes and systems |
US20090306630A1 (en) * | 2008-06-04 | 2009-12-10 | Christopher Brian Locke | Reduced-pressure, liquid-collection canister with multi-orientation filter |
US8172818B2 (en) * | 2008-06-04 | 2012-05-08 | Kci Licensing, Inc. | Reduced-pressure, liquid-collection canister with multi-orientation filter |
US20100125258A1 (en) * | 2008-11-14 | 2010-05-20 | Richard Daniel John Coulthard | Fluid pouch, system, and method for storing fluid from a tissue site |
US20110230848A1 (en) * | 2010-03-16 | 2011-09-22 | Michael Manwaring | Epithelialization methods, dressings, and systems |
US20110288512A1 (en) * | 2010-05-18 | 2011-11-24 | Christopher Brian Locke | Reduced-pressure medical systems and methods employing a moisture processing device |
US20120016323A1 (en) * | 2010-07-19 | 2012-01-19 | Kci Licensing, Inc. | Inflatable off-loading wound dressing assemblies, systems, and methods |
US20120046624A1 (en) * | 2010-08-18 | 2012-02-23 | Christopher Brian Locke | Reduced-pressure, multi-orientation, liquid-collection canister |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110125113A1 (en) * | 2008-06-23 | 2011-05-26 | Carmeli Adahan | Tissue enclosure |
US20170348154A1 (en) * | 2011-06-24 | 2017-12-07 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
US10973696B2 (en) | 2011-06-24 | 2021-04-13 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
US11364152B2 (en) * | 2011-06-24 | 2022-06-21 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
US20220273499A1 (en) * | 2011-06-24 | 2022-09-01 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
US11850351B2 (en) * | 2011-06-24 | 2023-12-26 | 3M Innovative Properties Company | Reduced-pressure dressings employing tissue-fixation elements |
Also Published As
Publication number | Publication date |
---|---|
US10064759B2 (en) | 2018-09-04 |
US20140107600A1 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11083629B2 (en) | Re-epithelialization wound dressings and systems | |
AU2015202851B2 (en) | Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers | |
US11007084B2 (en) | Moisture absorbing seal | |
US11529453B2 (en) | Reduced-pressure treatment and debridement systems and methods | |
US9352075B2 (en) | Wound healing apparatus for promoting granulation and epithelialization at a tissue site | |
EP2723286B2 (en) | Reduced-pressure dressings employing tissue-fixation elements | |
US10064759B2 (en) | Reduced-pressure wound dressings and systems for re-epithelialization and granulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOCKE, CHRISTOPHER BRIAN;ROBINSON, TIMOTHY MARK;COULTHARD, RICHARD DANIEL JOHN;REEL/FRAME:035980/0758 Effective date: 20091102 |